WANG Jing,JIA Yueping,LIU Guilan,LU Aidong,ZHANG Leping,ZUO Yingxi,WANG Bin. Different induction therapies in the treatment of childhood acute promyelocytic leukemia [J]., 2014, 32(5): 405-409.
[1] Shen ZX，Shi ZZ，Fang J，et al. All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia [J]. Proc Natl Acad Sci U S A，2004，101(15)：5328-5335. [2] Iland HJ，Bradstock K，Supple SG，et al. All-trans-retinoic acid，idarubicin，and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4) [J]. Blood，2012，120(8)：1570-1580，1752.. [3] Dai CW，Zhang GS，Shen JK，et al. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients [J]. Acta Haematol，2009，121(1)：1-8. [4] Fenaux P，Chastang C，Chevret S，et al. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group [J]. Blood，1999，94(4)：1192-1200. [5] 张之南，沈悌. 血液病诊断及疗效标准 [M]. 3版. 北京：北京科学技术出版社，2007：106-133. [6] Fenaux P，Le Deley DM，Castaigne S，et al. Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group [J]. Blood，1993，82(11)：3241-3249. [7] Breen KA，Grimwade D，Hunt BJ. The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia [J]. Br J Haematol，2012，156(1)：24-36. [8] Campos L，Guyotat D，Archimbaud E，et al. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis [J]. Blood，1992，79(2)：473-476. [9] 王冠军，李薇，崔久嵬，等. 三氧化二砷联合小剂量全反式维甲酸诱导急性早幼粒细胞白血病缓解的疗效分析 [J]. 中国医学杂志，2005，85(16)：1093-1096. [10] Ravandi F，Estey E，Jones D，et al. Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid，arsenic trioxide，and gemtuzumab ozogamicin [J]. J Clin Oncol，2009，27(4)：504-510. [11] 刘元昉，沈志祥，陈晓，等. 全反式维甲酸联合三氧化二砷治疗初发急性早幼粒细胞白血病的近期疗效观察 [J]. 中华血液学杂志，2003，24(1)：25-27. [12] 赵耀中，李洪强，李大鹏，等. 三氧化二砷联合全反式维甲酸治疗急性早幼粒细胞白血病的初步观察 [J]. 中华血液学杂志，2003，24(1)：32-34. [13] de Botton S，Chevret S，Coiteux V，et al. Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts：results from APL 93 trial [J]. Leukemia，2003，17(2)：339-342. [14] 郭为民，诸江，王鸿利，等. 维甲酸、砷剂及柔红霉素对NB4细胞组织因子表达的影响 [J]. 中华血液学杂志，1999，20(9)：453-455. [15] 史家岚，李金梅，侯金晓，等. 三氧化二砷和柔红霉素对急性早幼粒细胞白血病细胞的促凝血活性的影响 [J]. 中华医学杂志，2012， 92(16)：1095-1099. [16] 胡炯，沈志祥，仇倩瑶，等. 急性早幼粒细胞白血病纤溶异常研究 [J]. 中华血液学杂志，1997，18(1)：45-46. [17] Falanga A，Iacoviello L，Evangelista V，et al. Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid [J]. Blood，1995，86(3)：1072-1081. [18] de la Serna J，Montesinos P，Vellenga E，et al. Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-transretinoic acid and idarubicin [J]. Blood，2008，111(7)：3395-3402.
